Page last updated: 2024-08-23

substance p and Pulmonary Eosinophilia

substance p has been researched along with Pulmonary Eosinophilia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, LJ; Barskey, A; Haynes, LM; Jones, LP; Tripp, RA1
Graham, BS; Johnson, TR1

Reviews

1 review(s) available for substance p and Pulmonary Eosinophilia

ArticleYear
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:1 Suppl

    Topics: Animals; Antigens, Viral; Disease Models, Animal; Epitopes; Female; Glycoproteins; Immunity; Immunization; Interleukin-4; Interleukin-8; Male; Mice; Mice, Inbred BALB C; Pulmonary Eosinophilia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Severity of Illness Index; Substance P; Viral Vaccines

2004

Other Studies

1 other study(ies) available for substance p and Pulmonary Eosinophilia

ArticleYear
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.
    Journal of virology, 2003, Volume: 77, Issue:18

    Topics: Amino Acid Motifs; Animals; CD4-Positive T-Lymphocytes; Cell Movement; Chemokines; Chemokines, CX3C; CX3C Chemokine Receptor 1; Female; Formaldehyde; Membrane Proteins; Mice; Mice, Inbred BALB C; Pulmonary Eosinophilia; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Chemokine; Respiratory Syncytial Viruses; RNA, Messenger; Substance P; Vaccination; Vaccines, Inactivated; Viral Proteins; Viral Vaccines

2003